Press Releases
About Us
Executive Management
Board of Directors
Palatin Scientific Advisors
Careers at Palatin
Corporate Governance
Reporting Hotline
Research Focus
Clinical Pipeline
Our Focus: Peptide Drugs
Female Sexual Dysfunction
HSDD
Bremelanotide License
Bremelanotide
Phase 3 Reconnect Studies
Phase 2B Clinical Trial Results
Heart Failure
Inflammatory Disease
Obesity and Diabetes
Licensing & Collaboration
Investors
Overview
Press Releases
Event Calendar
Archived Events
Webcasts
SEC Filings
Analyst Coverage
Investor Resources
Resources
Corporate Presentation
Bremelanotide for Hypoactive Sexual Desire Disorder (HSDD)
Poster Presentations
Female Sexual Dysfunction Related Videos: Expert Discussion
Scientific Publications
Patent Portfolio
Helpful Links
Contact Us
Contacting Palatin
Resources
Corporate Presentation
Palatin Technologies Corporate Presentation May 2018
